Therefore, an efficient HIF-2α inhibitor that has no side effects on fetal growth or maternal health can be used as a promising drug for the suppression of hypertension and proteinuria, resulting in significant elongation of pregnancy period. The gene discussed is EPAS1; the disease is hypertensive disorder.